Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Arc Bio provides research and development in the physical, engineering, and life sciences.
Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.
Lightengale develops medical devices for improved ICU infusion lines.
HealthRhythms develops a mental health assessment and treatment platform to measure and monitor health conditions.
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Trace Matters is a technology startup focused on developing next generation of mass spectrometry technologies for a variety of applications.
Bleep provides best new CPAP solution on the market.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
Biotechnology company inspired by globin chemistry and protein engineering focused on developing breakthrough antidotal therapies.
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
dfusion, a team of scientists and innovators, develops technology to promote evidence-based, health-related behavioral changes.
Vibrato Medical is a medical device company developing wearable treatments for peripheral arterial disease.
Tabula Rasa enables medication optimization using its medication risk mitigation technology.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
Cerecor discovers, develops and commercializes neuroscience drugs.
Xtrava is a developer of applications for health and wellness.
Quadrant Biosciences is an epigenetic diagnostics company focusing on the early detection of neurological disorders.
Visikol is a contract research organization focused on digital pathology, 3D tissue imaging and 3D cell culture assays and models.
Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.
NeuraMedica is a medical device company developing a novel, bioabsorbable surgical clip to provide closure of the dura mater.
Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication.
Photonic Pharma is an early phase of drug development
Novosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Hospital, Medical Device. The firm invests across 29 different industry categories.
Among tracked funding rounds, CODA Biotherapeutics received $28.0M in a Series Unknown round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Arc Bio LLC, Epitel, Lightengale, HealthRhythms, Anavasi Diagnostics. These companies were founded in 2020 or later.